NCT02560220View on ClinicalTrials.gov

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 5, 2015

Primary Completion Date

April 18, 2017

Study Completion Date

April 18, 2017

Conditions
Kidney Failure, Chronic
Interventions
BIOLOGICAL

Mitomycin C-induced peripheral blood mononuclear cells (MICs)

MICs are given intravenously 2 or 7 days before kidney transplantation from a living donor

Trial Locations (1)

69120

University of Heidelberg, Heidelberg

All Listed Sponsors
collaborator

WiSP GmbH

OTHER

collaborator

German Federal Ministry of Economics and Technology

OTHER_GOV

lead

Heidelberg University

OTHER

NCT02560220 - MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter